Clarient Shareholders Tender 80 Percent of Shares in GE Healthcare Acquisition | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Stockholders of Clarient have tendered around 80 percent of their shares to GE Healthcare as the initial offering period for the acquisition closed last night.

GE Healthcare launched the $580 million acquisition offer for the molecular diagnostics and imaging firm in early November.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.